ClinicalTrialsFinder
CompletedPhase 1ACTRN12607000219482

Treatment of Anxiety and Depression in Head and Neck Cancer Patients

Treatment of Anxiety and Depression in Head and Neck Cancer Patients: An Evaluation of Cognitive Behaviour Therapy and Supportive Counselling

Sponsor

Dr Maria Kangas, Macquarie University Sydney Australia

Enrollment

160 participants

Start Date

Sep 5, 2007

Study Type

Interventional

Conditions

Anxiety (including Acute Stress Disorder and Posttraumatic Stress Disorder) in Head and Neck Cancer.Depression in Head and Neck Cancer.

Summary

The overall aim of this research is to test the efficacy of a brief, early cognitive-behavioural therapy (CBT) intervention in reducing anxiety [including cancer-related Posttraumatic Stress Disorder (PTSD)], and/or depression and improving the psychological well-being and quality of life for adult individuals newly diagnosed with head and neck cancer (HNC) who have been scheduled to receive radiation treatment. It is hypothesized that the CBT program (experimental condition) will help reduce anxiety and depressive symptoms both in the short- and longer-term (up to 12-months) following the completion of patients’ radiotherapy regimens, compared with a non-directive Supportive Counselling (SC) program (active control condition).

Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 70 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests treatments for anxiety and depression in people with head and neck cancer. This study is open to both men and women aged 18 to 70. Participation involves receiving psychological support or treatment and completing mood assessments throughout your cancer care.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Participants who are recently diagnosed with a first onset head and neck cancer (HNC) and who report experiencing acute stress symptoms and/or depressive symptoms within the initial 4-6 weeks post-can

Participants who are recently diagnosed with a first onset head and neck cancer (HNC) and who report experiencing acute stress symptoms and/or depressive symptoms within the initial 4-6 weeks post-cancer diagnosis and prior to commencing their radiotherapy (primary or adjuvant) will be randomly allocated to receive Cognitive Behaviour Therapy (CBT). The CBT intervention is a directive therapy that comprises relaxation, stress management and coping skills training. Therapy will be conducted on an individual face-to-face basis and will consist of 6 consecutive weekly meetings, 1.5 hours each, commencing on the same week as participants' scheduled radiotherapy program. Participants will also receive a booster (7th) session of CBT at 1-month following the completion of their radiotherapy.

Locations(1)

Royal Prince Alfred Hospital - Camperdown

NSW, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000219482